PROCEPT BioRobotics Corporation Common Stock (PRCT) is a publicly traded Healthcare sector company. As of August 18, 2026, PRCT trades at $20.84 with a market cap of $1.24B and a P/E ratio of -11.14. PRCT moved -3.81% today. Year to date, PRCT is -31.18%; over the trailing twelve months it is -46.04%. Its 52-week range spans $16.67 to $89.49. Analyst consensus is neutral with an average price target of $23.13. Rallies surfaces PRCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PRCT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $20.84 |
| Market Cap | $1.24B |
| P/E Ratio | -11.14 |
| EPS | $-1.94 |
| Dividend Yield | 0.00% |
| 52-Week High | $89.49 |
| 52-Week Low | $16.67 |
| Volume | 348.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $337.34M |
| Net Income | $-109.75M |
| Gross Margin | 64.22% |
11 analysts cover PRCT: 0 strong buy, 3 buy, 7 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $23.13.